Does catheter ablation improve outcomes in patients with cardiac sarcoidosis and ventricular tachycardia resistant to medical treatment?
Catheter ablation may be a viable option for medically refractory ventricular tachycardia in cardiac sarcoidosis, but current evidence is limited to low-quality observational data requiring future randomized trials.
These data support the utilization of catheter ablation in selected CS cases resistant to medical treatment. However, data are derived from observational non-controlled case series, with low-methodological quality. Therefore, future well-designed, randomized controlled trials, or large-scale registries are required.
Παπαγεωργίου et al. (Fri,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: